Afstyla and Dexbrompheniramine and phenylephrine
Determining the interaction of Afstyla and Dexbrompheniramine and phenylephrine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Afstyla (recombinant)
Generic Name: dexbrompheniramine / phenylephrine
Brand name: Ala Hist PE, Ala-Hist PE
Synonyms: Dexbrompheniramine and Phenylephrine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Afstyla-Dexbrompheniramine and Phenylephrine Syrup
- Afstyla-Dexbrompheniramine and Phenylephrine Tablets
- Afstyla-Dexbrompheniramine and pseudoephedrine
- Afstyla-Dexbrompheniramine and Pseudoephedrine Solution
- Afstyla-Dexbrompheniramine and Pseudoephedrine Sustained-Release Tablets
- Afstyla-Dexbrompheniramine and Pseudoephedrine Tablets
- Dexbrompheniramine and phenylephrine-Afstyla recombinant
- Dexbrompheniramine and phenylephrine-Aftera
- Dexbrompheniramine and phenylephrine-Aftertest Topical Pain Relief
- Dexbrompheniramine and phenylephrine-Agalsidase beta
- Dexbrompheniramine and phenylephrine-Agalsidase beta Intravenous
- Dexbrompheniramine and phenylephrine-Agenerase